Document Type
Article
Publication Date
11-23-2021
Abstract
Emerging epidemic-prone diseases have introduced numerous health and economic challenges in recent years. Given current knowledge of COVID-19, herd immunity through vaccines alone is unlikely. In addition, vaccination of the global population is an ongoing challenge. Besides, the questions regarding the prevalence and the timing of immunization are still under investigation. Therefore, medical treatment remains essential in the management of COVID-19. Herein, recent advances from beginning observations of COVID-19 outbreak to an understanding of the essential factors contributing to the spread and transmission of COVID-19 and its treatment are reviewed. Furthermore, an in-depth discussion on the epidemiological aspects, clinical symptoms and most efficient medical treatment strategies to mitigate the mortality and spread rates of COVID-19 is presented.
Recommended Citation
Zarkesh, K., Entezar-Almahdi, E., Ghasemiyeh, P., Akbarian, M., Bahmani, M., Roudaki, S., Fazlinejad, R., Mohammadi-Samani, S., Firouzabadi, N., Hosseini, M., & Farjadian, F. (2021). Drug-based therapeutic strategies for COVID-19-infected patients and their challenges. Future microbiology, 16, 1415–1451. https://doi.org/10.2217/fmb-2021-0116
Publication Title
Future Microbiology
DOI
10.2217/fmb-2021-0116
Comments
Copyright 2021 Future Medicine Ltd. Original published version available at https://doi.org/10.2217/fmb-2021-0116